Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 43 | 2013 | 674 | 6.430 |
Why?
|
| Muscle Fatigue | 29 | 2013 | 45 | 5.810 |
Why?
|
| Muscle Contraction | 27 | 2013 | 198 | 4.130 |
Why?
|
| Aging | 22 | 2013 | 723 | 3.280 |
Why?
|
| Isometric Contraction | 27 | 2012 | 45 | 3.250 |
Why?
|
| Energy Metabolism | 17 | 2013 | 349 | 1.830 |
Why?
|
| Adenosine Triphosphate | 9 | 2013 | 288 | 1.710 |
Why?
|
| Multiple Sclerosis | 13 | 2012 | 208 | 1.620 |
Why?
|
| Ischemia | 5 | 2010 | 192 | 1.260 |
Why?
|
| Torque | 5 | 2013 | 15 | 1.090 |
Why?
|
| Oxygen | 6 | 2011 | 308 | 1.070 |
Why?
|
| Oxygen Consumption | 8 | 2012 | 202 | 0.910 |
Why?
|
| Physical Endurance | 6 | 2009 | 48 | 0.870 |
Why?
|
| Regional Blood Flow | 7 | 2012 | 108 | 0.840 |
Why?
|
| Adult | 52 | 2013 | 15791 | 0.830 |
Why?
|
| Magnetic Resonance Spectroscopy | 16 | 2012 | 293 | 0.810 |
Why?
|
| Exercise | 15 | 2012 | 918 | 0.810 |
Why?
|
| Fatigue | 7 | 2010 | 104 | 0.760 |
Why?
|
| Phosphocreatine | 13 | 2012 | 24 | 0.730 |
Why?
|
| Muscle Weakness | 3 | 2013 | 29 | 0.710 |
Why?
|
| Muscles | 10 | 1996 | 171 | 0.680 |
Why?
|
| Male | 56 | 2012 | 27578 | 0.670 |
Why?
|
| Sex Characteristics | 7 | 2012 | 198 | 0.670 |
Why?
|
| Motor Neurons | 6 | 2013 | 206 | 0.660 |
Why?
|
| Electric Stimulation | 13 | 2011 | 139 | 0.650 |
Why?
|
| Renal Dialysis | 5 | 2006 | 185 | 0.630 |
Why?
|
| Electromyography | 14 | 2009 | 87 | 0.620 |
Why?
|
| Physical Exertion | 6 | 2009 | 78 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2011 | 2040 | 0.560 |
Why?
|
| Humans | 70 | 2013 | 59527 | 0.540 |
Why?
|
| Female | 49 | 2013 | 30924 | 0.530 |
Why?
|
| Mobility Limitation | 2 | 2013 | 49 | 0.510 |
Why?
|
| Phosphates | 5 | 2012 | 88 | 0.510 |
Why?
|
| Leg | 4 | 2008 | 83 | 0.510 |
Why?
|
| Aged | 26 | 2013 | 13346 | 0.490 |
Why?
|
| Myoglobin | 3 | 2010 | 27 | 0.480 |
Why?
|
| Young Adult | 11 | 2012 | 4332 | 0.450 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2013 | 1 | 0.430 |
Why?
|
| Gait | 2 | 2012 | 114 | 0.420 |
Why?
|
| Muscle Relaxation | 3 | 2009 | 25 | 0.420 |
Why?
|
| Knee | 2 | 2011 | 35 | 0.420 |
Why?
|
| Postural Balance | 2 | 2010 | 63 | 0.410 |
Why?
|
| Physical Fitness | 2 | 2012 | 92 | 0.410 |
Why?
|
| Computer Simulation | 2 | 2013 | 456 | 0.390 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 15 | 0.390 |
Why?
|
| Glycolysis | 3 | 2007 | 54 | 0.380 |
Why?
|
| Aged, 80 and over | 12 | 2013 | 5092 | 0.380 |
Why?
|
| Blood Volume | 2 | 2011 | 42 | 0.370 |
Why?
|
| Locomotion | 1 | 2012 | 110 | 0.370 |
Why?
|
| Motor Activity | 4 | 2009 | 343 | 0.360 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2012 | 427 | 0.360 |
Why?
|
| Middle Aged | 28 | 2012 | 16279 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 4 | 2006 | 193 | 0.320 |
Why?
|
| Ankle Joint | 5 | 2009 | 38 | 0.310 |
Why?
|
| Oxidative Phosphorylation | 4 | 2010 | 35 | 0.300 |
Why?
|
| Posture | 1 | 2008 | 127 | 0.300 |
Why?
|
| Age Factors | 5 | 2012 | 1518 | 0.280 |
Why?
|
| Rest | 3 | 2012 | 43 | 0.270 |
Why?
|
| Muscular Atrophy | 2 | 2006 | 26 | 0.270 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2000 | 474 | 0.270 |
Why?
|
| Central Nervous System | 2 | 1997 | 192 | 0.240 |
Why?
|
| Nervous System | 1 | 2005 | 69 | 0.240 |
Why?
|
| Analysis of Variance | 3 | 2012 | 576 | 0.230 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 133 | 0.220 |
Why?
|
| Models, Biological | 3 | 2013 | 1142 | 0.200 |
Why?
|
| Walking | 4 | 2012 | 229 | 0.200 |
Why?
|
| Oxidation-Reduction | 3 | 2012 | 305 | 0.190 |
Why?
|
| Ankle | 3 | 2008 | 19 | 0.180 |
Why?
|
| Mitochondria, Muscle | 2 | 2010 | 13 | 0.170 |
Why?
|
| Action Potentials | 5 | 2004 | 103 | 0.170 |
Why?
|
| Knee Joint | 2 | 2013 | 284 | 0.170 |
Why?
|
| Muscle Strength | 3 | 2009 | 37 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 636 | 0.160 |
Why?
|
| Biomechanical Phenomena | 4 | 2013 | 242 | 0.160 |
Why?
|
| Microcirculation | 2 | 2011 | 50 | 0.160 |
Why?
|
| Time Factors | 5 | 2011 | 3579 | 0.160 |
Why?
|
| Motor Neuron Disease | 1 | 1998 | 29 | 0.150 |
Why?
|
| Reference Values | 5 | 2001 | 321 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2008 | 1063 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2000 | 522 | 0.140 |
Why?
|
| Peripheral Nervous System | 1 | 1997 | 9 | 0.140 |
Why?
|
| Muscular Diseases | 2 | 1994 | 45 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2009 | 84 | 0.120 |
Why?
|
| Disability Evaluation | 2 | 2013 | 216 | 0.110 |
Why?
|
| Substance P | 2 | 1991 | 45 | 0.110 |
Why?
|
| Linear Models | 2 | 2012 | 422 | 0.110 |
Why?
|
| Kinetics | 3 | 2011 | 733 | 0.110 |
Why?
|
| Research Design | 1 | 1997 | 567 | 0.110 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1993 | 9 | 0.110 |
Why?
|
| Movement | 2 | 2004 | 146 | 0.100 |
Why?
|
| Bicycling | 1 | 2012 | 24 | 0.100 |
Why?
|
| Calcium | 2 | 1998 | 556 | 0.100 |
Why?
|
| Immobilization | 1 | 2012 | 12 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2012 | 27 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 484 | 0.100 |
Why?
|
| Fasciitis, Plantar | 1 | 2011 | 4 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 38 | 0.100 |
Why?
|
| Foot | 1 | 2011 | 41 | 0.100 |
Why?
|
| Volition | 2 | 2004 | 10 | 0.100 |
Why?
|
| Ion Channels | 1 | 2012 | 87 | 0.100 |
Why?
|
| Sex Factors | 2 | 2008 | 960 | 0.090 |
Why?
|
| Musculoskeletal System | 1 | 2011 | 9 | 0.090 |
Why?
|
| Adrenal Medulla | 1 | 1991 | 6 | 0.090 |
Why?
|
| Algorithms | 2 | 2009 | 990 | 0.090 |
Why?
|
| Vision, Low | 1 | 2010 | 9 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 449 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 265 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 125 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2000 | 86 | 0.080 |
Why?
|
| Mitochondria | 1 | 2012 | 337 | 0.080 |
Why?
|
| Creatine | 1 | 2009 | 26 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 43 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 59 | 0.080 |
Why?
|
| Resistance Training | 1 | 2009 | 20 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2008 | 16 | 0.080 |
Why?
|
| Brain | 1 | 1996 | 1489 | 0.070 |
Why?
|
| Reperfusion | 1 | 2007 | 37 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2001 | 2592 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 39 | 0.070 |
Why?
|
| Exercise Test | 1 | 2008 | 234 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2007 | 139 | 0.060 |
Why?
|
| Hyperemia | 1 | 2005 | 13 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 102 | 0.060 |
Why?
|
| Creatine Kinase | 1 | 2005 | 42 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2007 | 281 | 0.060 |
Why?
|
| Acidosis | 1 | 2005 | 24 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 1839 | 0.060 |
Why?
|
| Plethysmography | 1 | 2004 | 10 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2004 | 12 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 674 | 0.060 |
Why?
|
| Veins | 1 | 2004 | 61 | 0.060 |
Why?
|
| Body Composition | 2 | 2009 | 154 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2012 | 2470 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 117 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1186 | 0.050 |
Why?
|
| Phosphorus | 2 | 1994 | 18 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2003 | 250 | 0.050 |
Why?
|
| Phosphorus Isotopes | 2 | 1993 | 7 | 0.050 |
Why?
|
| Methods | 2 | 2000 | 39 | 0.050 |
Why?
|
| Neuromuscular Junction | 2 | 2001 | 82 | 0.050 |
Why?
|
| HIV Infections | 1 | 2009 | 921 | 0.050 |
Why?
|
| Postmenopause | 2 | 2001 | 246 | 0.050 |
Why?
|
| Massachusetts | 1 | 2008 | 2089 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 1095 | 0.050 |
Why?
|
| Child | 1 | 2010 | 4306 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2000 | 38 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2000 | 12 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2000 | 35 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2000 | 30 | 0.040 |
Why?
|
| Creatinine | 1 | 2000 | 123 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2000 | 51 | 0.040 |
Why?
|
| Adolescent | 1 | 2010 | 5932 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2000 | 118 | 0.040 |
Why?
|
| Organ Size | 2 | 2011 | 161 | 0.040 |
Why?
|
| Heart Rate | 1 | 2000 | 306 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1998 | 28 | 0.040 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1997 | 4 | 0.040 |
Why?
|
| Succinate Dehydrogenase | 1 | 1997 | 18 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 1997 | 29 | 0.040 |
Why?
|
| Animals | 3 | 2012 | 19663 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 1997 | 7 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 1551 | 0.030 |
Why?
|
| Myosins | 1 | 1998 | 109 | 0.030 |
Why?
|
| Data Collection | 1 | 1997 | 384 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 298 | 0.030 |
Why?
|
| Postpoliomyelitis Syndrome | 1 | 1994 | 2 | 0.030 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 2 | 1991 | 2 | 0.030 |
Why?
|
| Disease Progression | 1 | 1998 | 1044 | 0.030 |
Why?
|
| Cattle | 2 | 1991 | 308 | 0.030 |
Why?
|
| Hydrogen | 1 | 1993 | 50 | 0.030 |
Why?
|
| Lactates | 1 | 1993 | 28 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 1449 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Chromaffin System | 1 | 1990 | 1 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 111 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 1991 | 31 | 0.020 |
Why?
|
| Wrist | 1 | 1991 | 32 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 1991 | 51 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 201 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1991 | 90 | 0.020 |
Why?
|
| Cytosol | 1 | 1991 | 169 | 0.020 |
Why?
|
| Nicotine | 1 | 1990 | 109 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 307 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1991 | 2104 | 0.020 |
Why?
|
| San Francisco | 1 | 2009 | 8 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2008 | 35 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 119 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 98 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 681 | 0.020 |
Why?
|
| Glycogen | 1 | 2001 | 46 | 0.010 |
Why?
|
| Estrogens | 1 | 2001 | 113 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 5184 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 1998 | 10 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1998 | 124 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1995 | 35 | 0.010 |
Why?
|